CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 15,100 shares at an average $10.10 ($152,517)
- 4 Open-market buy Director bought 282 shares at $9.61 ($2,710)
- 4 Open-market buy Director bought 4,718 shares at $9.42 ($44,444)
- 4 Open-market buy Director bought 15,000 shares at $10.00 ($150,000)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale
- UPLOAD Other SEC-generated Letter
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CERT Other Certification
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-A12B Other Registration of Securities
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
Page 17 of 26 · 511 filings